InvestSMART

Global X S&P Biotech ETF (ASX: CURE) - Dividends

Current share price for CURE : $50.500 0.56 (1.12%)+

Global X S&P Biotech ETF (CURE) is an Exchange Traded Fund - commonly known as an ETF. For more details about how ETFs work, feel free to check out our What is an ETF? overview. Global X S&P Biotech ETF (CURE, formerly ETFS S&P Biotech ETF) is an exchange traded fund that provides exposure to U.S. healthcare biotechnology companies. These companies are engaged in the research, development and manufacturing of products based on genetic analysis and genetic engineering.

Latest company dividends for Global X S&P Biotech ETF (CURE)

Sector Market Cap
($m)
Distribution Type Dividend Franking Ex-dividend date Payment date Current Price Price
7D Avg
Dividend
Yield
Financials $38 H F Result 2.4¢ 0% 30 Jun 2022 15 Jul 2022 $50.500 $50.750 -
Financials $38 H F Result $6.26 0% 30 Jun 2021 15 Jul 2021 $50.500 $50.750 -
Financials $38 H F Result $6.76 0% 30 Jun 2020 15 Jul 2020 $50.500 $50.750 -
Financials $38 Result $1.17 0% 28 Jun 2019 15 Jul 2019 $50.500 $50.750 -
  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.